Category: Featured Content
-
Interactive Games Technologies (BETS.C): The door is opening, and not just in North America
Adopting a sin as an acceptable, taxable business is slow going. From the moment our government overlords decide to un-ban a thing, it takes often years, even decades, to move through the many stages of evolution before it can become fully embraced by society. Take booze as an example. In the 1930’s, coming out of…
-
Canntab Therapeutics (PILL.C) racks up revenue as CBD caplets shipped to Medipharm (LABS.T)
Cannabis hard tablet IP holder Canntab Therapeutics (PILL.C) continues to send product to market, announcing Wednesday they’ve fulfilled 80% of their contract with Medipharm Labs (LABS.T), bringing in another half million dollars in revenue toward the $1.3 million deal announced last June. Orders under the agreement are a mix of Canntab’s proprietary instant release tablets…
-
Earthrenew (ERTH.C) signs an L.O.I. with 50,000 cattle facility in the U.S.
The demand-drivers for ERTH’s products have a macro tail-wind (the stock is up 75% year-to-date). Due to the encroachment of suburbs, arable land is being lost at the rate of over 38,000 square miles per year.
-
Zacatecas Silver (ZAC.V): A tight new silver stock from a miner with a hot hand
Bryan Slusarchuk’s Zacatecas Silver (TSXV:ZAC) trades Tues Mar 2, 2021, with over $9 million in cash, only 52.3 million shares out and no warrants. Few mining entrepreneurs ever took advantage of a bear market better than Canadian Bryan Slusarchuk in 2015. He and an elite team of mine-builders picked up a Papua New Guinea gold…
-
How Field Trip (FTRP.CN) is scaling its ketamine therapy operations following a giant raise
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD but was later upsized to $82.9M CAD. It was priced at $6.50 CAD per share, adding 12.8M shares to the pool, bringing the number of shares…
-
What is a NFT and Can Somebody Make It Go Away?
This is insane. It was the morning of February 24th, 2021. The sun was half-shining and I had happily forgone the online Pilates class I’ve been planning to do for weeks. I was brewing my third cup of Nespresso coffee when assaulted by the headline: “Picasso, Rothko, Cézanne, Warhol, and…Beeple?” Who is Beeple? You may…
-
Aequus Pharma (AQS.V) launches Evolve Eyedrops to eye care professionals in Canada
Aequus is a $24 million pharmaceutical company focused on developing and commercializing high quality, differentiated products.
-
North Arrow Minerals (NAR.V): A fancy, contrarian investment opportunity
Tulips were introduced to the Netherlands in the late 1500s and the country soon fell in love with the brightly coloured flowers. Their arrival coincided with the Dutch Golden Age, when control of lucrative trading routes to the Far East made the Netherlands a marine superpower and one of the world’s wealthiest nations. Trade and…
-
Revive Therapeutics (RVV.C) finds $23 million and throws it at their bucillamine clinical studies
Revive Therapeutics (RVV.C) provided an update on their Phase 3 clinical trial for bucillamine for COVID-19 today. Primarily, the update’s about funding and more specifically their recent $23 million financing. The company intends to use the monies to fund their aggressive expansion from14 clinical sites to 50 to meet their enrolment requires for the study…
-
Delic Holdings (DELC.C) acquires licensed psilocybin/cannabis lab, is doing legal shroom business
For a year, naysayers have dismissed the early stage shroom boom as being a pumpy bunch of pubco RTOs that won’t be able to do business legally for years. To be fair, there’s some basis to that dismissal. But only some. We’ve also been talking about how Delic Holdings (DELC.C) was an all-star team of…